Ophthalmic Drugs Conference 2019

3rd Annual Ophthalmic Drugs Conference is organized by SMi Group Ltd and will be held from Nov 18 - 20, 2019 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.

Who Should Attend:
Chief, Vice Presidents, Heads, Senior Directors, Directors, Principals, Principal Scientists, Team/ Project Leaders, Clinicians, Clinical Trial Managers, Medical Officers of:
• Ophthalmology 
• Ophthalmic devices 
• Drug Delivery 
• Drug discovery 
• Research and development 
• Clinical development 
• Quality assurance 
• Immunology, Inflammation and Allergies 
• Market Access 
• Global Presence

Benefits of Attending:
• Explore novel approaches to delivery of ocular drugs
• Understand late-stage clinical development programs through real-world examples
• Delve into novel delivery methods for ophthalmic drugs via implants lenses and punctal plugs
• Learn how micro-dosing technologies are being used for the treatment of ocular disease
• New for 2019: focus day on the challenges of drug delivery through a complex barrier

Description:
The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.

With that in mind, SMi is proud to present the 3rd Annual Ophthalmic Drugs Conference taking place on the 19th-20th of November 2019, in London.

As Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in the treatment of ocular rare disease, innovations in gene therapy, the challenges in drug delivery through a complex barrier, patient comfort, and regulatory compliance which make up such core components within the Ophthalmic Drug sphere.

This three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.

Workshop:
Overview:
SMi is proud to present the New Ophthalmic Drugs Focus Day - Novel Drug Delivery Through a Complex Barrier

Introducing the only ophthalmic conference to hold a full day exploring alternatives to intravitreal delivery to the posterior segment of the eye. With the global ophthalmic drug market currently valued at $17,364 million USD, this focus day will asses the growing need for research and development of novel delivery approaches to expand the current ophthalmic delivery methods in today's market.

In conjunction with Europe’s leading Ophthalmic Drugs conference, we will explore new discoveries in novel drug delivery through case studies, regulatory outlooks and industry examples to give a comprehensive overview of the Ophthalmic Drug Delivery space.

This focus day offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more.

We look forward to welcoming you to the conference in November. 

Benefits of Attending:
• Learn how leaders in big Pharma and research are unveiling innovations in ophthalmic drug delivery 
• Explore novel approaches to delivery of ocular drugs including: the use of stimuli-responsive hydrogels, thermally induced phase separation, lenses and implants
• Network with the leading pharmaceutical and biotech companies developing novel delivery methods